Neuropsychiatria i Neuropsychologia is a pivotal journal dedicated to the exploration of behavioral neuroscience, neuropsychology, and psychiatry, published by TERMEDIA PUBLISHING HOUSE LTD in Poland. This journal, with an ISSN of 1896-6764, has been a significant contribution to the scientific community since its inception in 2009 and continues to converge its findings until 2024. While it operates under a traditional access model, its commitment to disseminating research in these critical fields is unwavering. The journal currently holds a Q4 classification in multiple categories including Behavioral Neuroscience and Neuropsychology, reflecting its growing influence in the landscape of mental health studies. With Scopus rankings displaying a percentile standing in the bottom quartile, Neuropsychiatria i Neuropsychologia presents an opportunity for authors and researchers to contribute and engage with emerging findings in psychiatry and behavioral science. By fostering scholarly communication and collaboration, this journal serves as a valuable resource for researchers, professionals, and students seeking to advance their understanding and knowledge within these vital areas of study.

Frontiers in Human Neuroscience is a premier open access journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the complexities of human neuroscience. With an ISSN of 1662-5161, the journal has established its prominence in various fields, achieving a Q2 ranking in categories such as Behavioral Neuroscience, Neuropsychology and Physiological Psychology, and Psychiatry and Mental Health as of 2023. Since its inception in 2008, Frontiers in Human Neuroscience has consistently contributed to the scholarly dialogue by offering a platform for innovative research that bridges the gap between neuroscience and behavioral science. The journal's rigorous peer-review process and commitment to open access ensures that findings are readily available, promoting collaboration and progress within the academic community. With an impact on neuroscience disciplines, it stands at the forefront of the field, inviting researchers, professionals, and students alike to engage with cutting-edge studies and developments. The journal's address is located in Lausanne, Switzerland, where it continues to flourish as a hub for neurobiological exploration.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Brain Impairment, published by Cambridge University Press, is a pivotal academic journal dedicated to advancing the understanding of neurological conditions and cognitive processes. With its ISSN 1443-9646 and E-ISSN 1839-5252, this esteemed journal has been at the forefront of research in the fields of Behavioral Neuroscience, Cognitive Neuroscience, and Neuropsychology since its inception in 2004. Covering a broad scope, it addresses critical insights into brain function, impairments, and therapies, making it a valuable resource for researchers, clinicians, and students alike. Brain Impairment holds various rankings, including Q4 in Behavioral Neuroscience and Q2 in Speech and Hearing, reflecting its significance in the academic community. While the journal operates under print access, its rich content serves as an essential reference for professional development and scholarly discussion in the UK and beyond. Researchers and practitioners can rely on this journal to provide cutting-edge research and reviews that inform clinical practice and shape future studies in neurology and cognitive neuroscience.

Aging Brain is a premier Open Access journal published by Elsevier, dedicated to advancing the understanding of the neurobiological changes associated with aging. Since its commencement in 2021, this journal has been pivotal in disseminating high-quality research that explores the intricate relationships between aging and cognitive functions, neurological disorders, and overall brain health. With a notable commitment to open accessibility, Aging Brain ensures that vital findings are available to a global audience, fostering collaboration and innovation in the field. Researchers, healthcare professionals, and students alike will find a rich repository of cutting-edge studies, reviews, and insights aimed at addressing the complexities of the aging brain. The journal stands as an influential platform for those passionate about enhancing the quality of life for the aging population, making it a valuable resource in gerontology and neuroscience.

NEUROBIOLOGY OF AGING, published by Elsevier Science Inc, is a premier journal dedicated to advancing our understanding of the complex interactions between the aging process and neurobiological mechanisms. With an ISSN of 0197-4580 and E-ISSN 1558-1497, the journal has established itself as a critical resource in the fields of Aging, Developmental Biology, Geriatrics and Gerontology, Clinical Neurology, and Neuroscience. Boasting a Q1 ranking in multiple categories, the journal is positioned within the top echelons of scholarly publication, underscoring its significant impact with an impressive Scopus ranking in various subfields. Committed to disseminating high-quality, peer-reviewed research, NEUROBIOLOGY OF AGING welcomes original articles, reviews, and research notes aiming to uncover the underlying processes of aging on the nervous system, fostering collaboration among researchers, professionals, and students alike. Although primarily subscription-based, the journal continues to play a vital role in shaping the discourse on aging and neurobiology, making it an essential publication for those engaged in this dynamic field.

Cognitive and Behavioral Neurology is a prominent peer-reviewed journal dedicated to advancing the understanding of cognitive and behavioral aspects of neurological disorders. Published by Lippincott Williams & Wilkins, this journal has established itself as a vital resource for researchers, clinicians, and students in the fields of cognitive neuroscience, neuropsychology, and psychiatry. With an ISSN of 1543-3633 and an E-ISSN of 1543-3641, it offers a robust platform for the dissemination of high-quality research, as evidenced by its positioning in the Q3 quartiles across various categories, including Cognitive Neuroscience and Psychiatry. The journal, which has been actively publishing since 2003, encourages innovative studies that explore the intersection of cognition and behavior in neurological contexts. As a vital contributor to the academic dialogue on these topics, it provides an essential archive of findings and discussions that inform clinical practice and educational approaches, reflecting its commitment to improving patient outcomes and enhancing neurological science.

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, published by Lippincott Williams & Wilkins, is a pivotal journal for advancing knowledge in the fields of clinical psychology, geriatric medicine, and psychiatry. With a history spanning from 1987 to 2024, this journal provides a comprehensive platform for researchers and clinicians to disseminate significant findings related to Alzheimer's disease and associated cognitive disorders. Ranked within the second and third quartiles in various categories, including clinical psychology and geriatrics, it retains a solid academic reputation, indicated by its diverse Scopus rankings, such as #137 in Clinical Psychology and #20 in Nursing & Gerontology. Although it does not offer open access, the journal is recognized for its commitment to peer-reviewed research, making it a valuable resource for professionals and students alike, aiming to stay abreast of the latest developments and evidence-based practices in Alzheimer’s and associated conditions.

Developmental Cognitive Neuroscience is a leading interdisciplinary journal published by ELSEVIER SCI LTD, dedicated to advancing the field of cognitive neuroscience with a specific focus on the developmental aspects of brain function and behavior. Since its inception in 2011, this Open Access journal has continued to thrive, gaining significant recognition with a remarkable impact factor that places it in the Q1 category of cognitive neuroscience, ranking 22nd out of 115 in Scopus. This enhances its visibility and accessibility to a global audience, including researchers, clinicians, and students keen on exploring the intricate relationship between cognitive development and neurological processes. The journal embraces a wide array of topics, from the impact of early life experiences on cognitive outcomes to neurodevelopmental disorders, fostering an enriching platform for disseminating high-quality research and innovative findings. As it progresses towards 2024, Developmental Cognitive Neuroscience remains pivotal in shaping future research and understanding in the field.

CEREBRAL CORTEX, published by Oxford University Press Inc, is a premier journal dedicated to advancing the field of neuroscience, specifically focusing on the cellular, molecular, and cognitive aspects of cortical structure and function. With an impressive impact factor that situates it in the top quartile (Q1) of its categories for 2023, this journal holds significant relevance for researchers and professionals interested in the latest discoveries and methodologies in both Cognitive Neuroscience (ranked #31 out of 115) and Cellular and Molecular Neuroscience (ranked #48 out of 97). Operating without an open access model, it ensures rigorous peer review and dissemination of high-quality research from across the globe. Since its inception in 1991, CEREBRAL CORTEX has established itself as a critical platform for educators and inventors, pushing the boundaries of knowledge in understanding brain function and its implications for behavior. Researchers and students alike will find this journal an invaluable resource for both foundational and cutting-edge studies in neuroscience.